openPR Logo
Press release

Companion Animal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

03-16-2018 07:37 AM CET | Health & Medicine

Press release from: Market Research Report: CMI

Companion Animal Drugs Market - Global Industry Analysis, Size,

According to the report by Association for Pet Obesity Prevention (APOP), in 2016, there is a continuous increase in pet obesity, affecting around 54% of dogs and 59% of cats in U.S. Pet obesity is a major problem in U.S., which increases the pain and suffering and also affects the life expectancy of companion animal or pet. According to APOP, factors causing pet obesity include negligence of pet owners and veterinary professionals in providing nutritional diet such as corn, grains, and raw and organic diet. In 2016, According to the stats by American Pet Products Association (APPA), around 41.9 million dogs and 50.5 million cats were classified into overweight or obese category by veterinary healthcare professionals.

According to the Mississippi State University, College of Veterinary Medicine, consumption of high calorific diet, genetic and age factors, are some of the factors accounted for obesity in the companion animal, which further lead to osteoarthritis, diabetes mellitus, hepatic lipidosis, cardiovascular disease, and early mortality. This is expected to augment the growth of companion animal drugs market in the near future.

Veterinary hospital/clinics segment are expected to become the more trusted distribution channel

According to the report by Federal Trade Commission (FTC) staff, in 2015, veterinarians and veterinary clinic or hospitals were accounted as the major distribution channel for pet medications. Nearly all major manufactures of pet medications distribute their medications through licensed veterinaries or through authorized veterinary distributors. Moreover, consumers purchase pet medications from veterinarians at the time of examination and diagnosis of their pet.

Ask for detailed Sample of the Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1203

*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it

Key Players in the Global Companion Animal Drug Market

Some of the major players operating in the companion animal drugs market include Merck Animal Health, Elanco, Zoetis, Boehringer Ingelheim GmbH, Virbac, Ceva Sante Animale, Bayer AG, Dechra Pharmaceuticals PLC, and Vetoquinol SA.

According to the report published by Federal Trade Commission (FTC), in 2015, U.S. spent around US$ 58 billion in 2014 on their companion animals, which include food, veterinary care, prescription, and OTC medications, and other pet services and products. Moreover, U.S. companion animal drugs market is significantly growing in both prescription and non-prescription based medications. Growing rate of companion animal ownership, progressive rate in pet health insurance, and longer life expectancy of companion animals due to the advances in animal health medication, expected to drive the growth of companion animal drugs market in the near future. According to the North American Pet Health Insurance Association (NAPHIA), in 2015, there is an increase of US$ 774 million in overall gross written premium (GWP), accounting to 17.2 percent growth in GWP. In 2015, around 1.6 million pets got secured with health insurance, increasing to 12% from 2014 to 2015.

However, growing antimicrobial drug resistance is the major factor hindering the growth of companion animal drugs market. According to the report by the University of Illinois at Urbana Champaign (UIUC), in 2017, methicillin-resistant staphylococcus is a prevalent infection in companion animals, accounted to around 40% in North America, 20% in Europe, 12% in Australia, and 48% in China. U.S. Food & Drug Administration (FDA) started Center for Veterinary Medicine (CVM), which is engaged in various activities to address the threat of antimicrobial resistance, by protecting human and animal health.

Companion animal drugs market taxonomy:

By Product Type:

Antibiotics,Parasiticides,Ecto- parasiticides,Endo- parasiticides,Anti-inflammatory drugs,Nutritional drugs,Behavioral drugs,Heartworm drugs,Skincare drugs,Vaccines,.

By Animal Type:

Feline,Canine,Equine,Others,.

By Distribution Channel:

Veterinary hospitals,Veterinary clinics,Pharmacy/ drug store,.

To know more about the Companion Animal Drugs Market , click the link below: https://www.coherentmarketinsights.com/ongoing-insight/companion-animal-drugs-market-1203

“Catch us at 3rd International Conference on Separation + Drying Technologies for Milk & Whey at Cologne, March 19 and 20, 2018”

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Animal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 here

News-ID: 981026 • Views:

More Releases from Market Research Report: CMI

Pompe Disease Therapeutic Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Pompe Disease Therapeutic Market- Global Industry Analysis, Size, Share, Growth, …
Manufacturers are focusing on finding new solutions by expanding their pipeline to cater the demand for pompe disease therapeutics market. For instance, in September, 2017, Avrobio Inc. expanded their products pipeline with gene therapy to treat pompe disease by utilizing a proprietary lysosomal targeting sequence to deliver high levels of enzyme to lysosomes. Furthermore, in October 2017, Amicus Therapeutics received orphan drug designation to ATB200/AT2221 from the U.S. FDA for
Immuno-oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Immuno-oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Tr …
Active research and development by leading players as well as small innovative organizations are expected to boost growth of the immune-oncology drugs market According to the World Health Organization (WHO), cancer was responsible for 8.8 million deaths in 2015. Owing to benefits associated with these therapies, the leading players are actively investing in research and development into this treatment category through various collaborations and individual research studies. For instance, EMD Serono
Blood Clotting Factors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Blood Clotting Factors Market - Global Industry Analysis, Size, Share, Growth, T …
Haemophilia is a rare disorder affecting very small fraction of population across the globe. Pharmaceutical companies invest less amount on development of such drugs due to low return on investment. However, FDA has recognised this fact and has formulated favourable policy to motivate companies to invest in this area. Orphan Drug Act that applies to company operating in this area provides three special incentives i.e. 7 years exclusivity period, tax
Chagas Disease Treatment Market - Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Chagas Disease Treatment Market - Insights, Trends, Outlook, and Opportunity Ana …
In 2017, Food and Drug Administration (FDA) approved benznidazole for children suffering from Chagas, in the age group of 2 to 12 years. This is the first approved safe and effective therapeutic for Chagas in the U.S. FDA granted benznidazole priority review and orphan product designation, as it is a rare disease and there have been no approved drugs for its treatment in the U.S. This approval is expected to

All 5 Releases


More Releases for Animal

Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report
Animal Hormones Market Brief Analysis By Top Key Players - Bayer Animal Health, …
MarketStudyReport.com adds a new 2018-2023 Global Animal Hormones Consumption Market Report focuses on the major drivers and restraints for the global key players providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. This report presents a comprehensive overview, market shares, and growth opportunities of Animal Hormones Market by product type, application, key manufacturers and key regions. Over the next five years, Animal Hormones market will
Global Animal Healthcare Market 2018 Key Players: Merck, Bayer Animal Health, Bo …
Animal Healthcare Market: WiseGuyReports.com adds “Animal Healthcare Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database. Executive Summary This report studies the global Animal Healthcare market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Animal Healthcare market by companies, region, type and end-use industry. This report focuses on the global top players, covered Merck Bayer Animal Health Boehringer Ingelheim Animal Hipra Phirbo Animal
Companion Animal Healthcare Market 2023 Leading Players | Bayer Animal Health (G …
The Global Companion Animal Healthcare Market is expected to reach USD 20 billion by 2023 at a CAGR of 9.6% during forecast period 2017 to 2023. Companion animals are pets which are kept for protection of a person, company, property or residence. These animals help to avoid theft and render safe environment. Dog and cats are the most popular pets. Companion animals play an important role in the lives of many,